XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restricted Stock Units (RSUs)        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 1,098,100 1,003,400 990,100 841,300
Granted (in shares) 81,300 175,300 453,700 520,500
Vested (in shares) (83,000.0) (66,400) (315,900) (227,100)
Forfeited (in shares) (14,300) (39,600) (45,800) (62,000.0)
Unvested at end of period (in shares) 1,082,100 1,072,700 1,082,100 1,072,700
Performance Shares [Member]        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 511,400 463,600 458,100 567,000.0
Granted (in shares) 0 2,400 168,800 185,200
Vested (in shares) 0 0 (109,000.0) (257,200)
Forfeited (in shares) (1,800) (4,200) (8,300) (33,200)
Unvested at end of period (in shares) 509,600 461,800 509,600 461,800
Share-based Payment Arrangement [Member]        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 1,609,500 1,467,000 1,448,200 1,408,300
Granted (in shares) 81,300 177,700 622,500 705,700
Vested (in shares) (83,000.0) (66,400) (424,900) (484,300)
Forfeited (in shares) (16,100) (43,800) (54,100) (95,200)
Unvested at end of period (in shares) 1,591,700 1,534,500 1,591,700 1,534,500
Share-based Payment activity, additional disclosures [Abstract]        
Weighted average grant date fair value, beginning of period (in dollars per share) $ 180.52 $ 174.54 $ 175.07 $ 170.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 246.99 165.96 205.79 143.64
Weighted average grant date fair value, vested (in dollars per share) 181.41 145.97 184.44 120.53
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 179.09 176.43 174.50 161.55
Weighted average grant date fair value, end of period (in dollars per share) $ 184.62 $ 174.73 $ 184.62 $ 174.73
Weighted average remaining contractual life, unvested shares outstanding     1 year 4 months 24 days  
Unamortized deferred compensation cost $ 107.2   $ 107.2